TY  - JOUR
AU  - Alcolea Alcolea, Pedro José
AU  - Larraga, Jaime
AU  - Rodríguez-Martín, Daniel
AU  - Alonso, Ana
AU  - Loayza, Francisco
AU  - Rojas, José M.
AU  - Ruiz García, Silvia
AU  - Louloudes Lázaro, Andrés
AU  - Carlón, Ana B.
AU  - Sánchez Cordón, Pedro José
AU  - Nogales Altozano, Pablo
AU  - Redondo, Natalia
AU  - Manzano García, Miguel
AU  - Lozano Borregón, Daniel
AU  - Palomero, Jesús
AU  - Montoya, María
AU  - Vallet Regí, María Dulce Nombre
AU  - Martín García, Verónica
AU  - Sevilla, Noemí
AU  - Larraga, Vicente
PY  - 2022
DO  - 10.3389/fimmu.2022.1023255
SN  - 1664-3224
UR  - https://hdl.handle.net/20.500.14352/73418
T2  - Frontiers in Immunology
AB  - SARS-CoV-2 vaccines currently in use have contributed to controlling the COVID-19 pandemic. Notwithstanding, the high mutation rate, fundamentally in the spike glycoprotein (S), is causing the emergence of new variants. Solelyutilizing this antigen is...
LA  - eng
PB  - Frontiers Media
KW  - SARS-CoV-2
KW  - DNA vaccine
KW  - S protein
KW  - N protein
KW  - Mouse model
KW  - pPAL
KW  - Furin
TI  - Non-replicative antibiotic resistance-free DNA vaccine encoding S and N proteins induces full protection in mice against SARS-CoV-2
TY  - journal article
VL  - 13
ER  -